OXY-KESSO-TETRA Drug Patent Profile
✉ Email this page to a colleague
When do Oxy-kesso-tetra patents expire, and what generic alternatives are available?
Oxy-kesso-tetra is a drug marketed by Ferrante and is included in one NDA.
The generic ingredient in OXY-KESSO-TETRA is oxytetracycline hydrochloride. There is one drug master file entry for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXY-KESSO-TETRA?
- What are the global sales for OXY-KESSO-TETRA?
- What is Average Wholesale Price for OXY-KESSO-TETRA?
Summary for OXY-KESSO-TETRA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| DailyMed Link: | OXY-KESSO-TETRA at DailyMed |
US Patents and Regulatory Information for OXY-KESSO-TETRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferrante | OXY-KESSO-TETRA | oxytetracycline hydrochloride | CAPSULE;ORAL | 060179-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
